Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Gentronix Awarded Grant of £147,552 by MRC and Technology Strategy Board

Published: Thursday, December 20, 2012
Last Updated: Thursday, December 20, 2012
Bookmark and Share
Company awarded grant from the Biomedical Catalyst programme for an epigenetic based screening assay feasibility study.

Gentronix Ltd., Manchester UK, has been awarded a grant of £147,552 by the Medical Research Council (MRC) and the Technology Strategy Board under the joint £180 million Biomedical Catalyst programme.

The project funded by the award will look at the feasibility of developing a screening assay for compounds that may cause cancer as a result of epigenetic mechanisms.

Before being approved for use, chemicals such as pharmaceuticals, agrochemicals and consumer products have to be tested for genetic toxicity i.e. their potential to change the DNA sequence or the number of chromosomes in a cell.

Exposure to genotoxic chemicals can lead to the development of cancers. They can be identified by routine screening tests used by laboratories such as Gentronix.

There are also non-genotoxic carcinogens that alter patterns of gene expression without changing the number or sequence of chromosomes.

There are currently no widely used screening tests available for these and they might only be identified in later animal exposure studies, which are time consuming, costly and come quite late in product development - an expensive time to fail.

Epigenetics is a relatively new field, concerned with the regulation of genes by chromosome modifications which don’t change the DNA sequence or chromosome numbers.

Epigenetic changes can also lead to the development of cancers and it is this aspect of early toxicology screening that the team at Gentronix Ltd., led by Chief Scientist, Prof. Richard Walmsley will be looking to address under the award.

Gentronix CEO, John Nicholson said “Gentronix has an excellent track record of innovation, and though as a growing company we have to balance innovative research with customer priorities, the award of this grant gives us the opportunity to carry out important fundamental research; the results of which will allow us to make informed decisions about the commercial potential of an epigenetics-based assay as well as making a contribution to the science of genetics”.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Improved In Vitro Genotoxicity Testing to Reduce Animal Testing
In conjunction with the University of Manchester, Gentronix has been granted a research award of £133,024.
Thursday, August 10, 2006
Gentronix Secures R&D Award
The two-year grant will provide Gentronix with two scientists, cell culture facilities, and supporting laboratory instrumentation at its Manchester Incubator Core Technology Facility premises.
Tuesday, April 11, 2006
Scientific News
RNAi Screening Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Sweet Revenge Against Superbugs
A special type of synthetic sugar could be the latest weapon in the fight against superbugs.
Access Denied: Leukemia Thwarted by Cutting Off Link to Environmental Support
A new study reveals a protein’s critical – and previously unknown -- role in the development and progression of acute myeloid leukemia (AML), a fast-growing and extremely difficult-to-treat blood cancer.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
The Light of Fireflies for Medical Diagnostics
EPFL scientists have exploited the light of fireflies in a new method that detects biological molecules without the need for complex devices and high costs.
Vital Protein in Healthy Fertilization Process Identified
Researchers at the National Institutes of Health have discovered a protein that plays a vital role in healthy egg-sperm union in mice.
Teeth Reveal Lifetime Exposures to Metals, Toxins
Researchers have identified dental biomarkers to reveal links between early iron exposure and late life brain diseases.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!